Patient Decision Aid (PDA) for Patients with Rheumatoid Arthritis Reduces Decisional Confict and Improves Readiness for Treatment Decision Making
Visualitza/
Impacte
Scholar |
Altres documents de l'autoria: Pablos, José Luis; Jover, Juan Ángel; Román-Ivorra, José Andrés; Inciarte-Mundo, Jose; Dilla, Tatiana; Sacristán, José Antonio; Comellas, Marta; Lizán, Luis
Metadades
Mostra el registre complet de l'elementcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/36080
comunitat-uji-handle3:10234/36082
comunitat-uji-handle4:
INVESTIGACIONMetadades
Títol
Patient Decision Aid (PDA) for Patients with Rheumatoid Arthritis Reduces Decisional Confict and Improves Readiness for Treatment Decision MakingAutoria
Data de publicació
2020Editor
SpringerISSN
1178-1653; 1178-1661Cita bibliogràfica
Pablos, J.L., Jover, J.A., Roman-Ivorra, J.A. et al. Patient Decision Aid (PDA) for Patients with Rheumatoid Arthritis Reduces Decisional Conflict and Improves Readiness for Treatment Decision Making. Patient 13, 57–69 (2020). https://doi.org/10.1007/s40271-019-00381-yTipus de document
info:eu-repo/semantics/articleVersió de l'editorial
https://link.springer.com/article/10.1007%2Fs40271-019-00381-yVersió
info:eu-repo/semantics/publishedVersionResum
Objectives The aim of this study was to develop and assess the efectiveness of a patient decision aid (PDA) to support
treatment decision making in Spanish patients with moderate-to-severe rheumatoid arthritis (RA) ... [+]
Objectives The aim of this study was to develop and assess the efectiveness of a patient decision aid (PDA) to support
treatment decision making in Spanish patients with moderate-to-severe rheumatoid arthritis (RA) who fail to achieve the
therapeutic goal with the current disease-modifying antirheumatic treatment strategy.
Methods The PDA was developed in accordance with the International Patient Decision Aids Standards recommendations. A
steering group led the project. Three literature reviews and two focus groups were performed to develop the PDA prototype.
To check its comprehensibility, acceptability, and feasibility, alpha-testing was performed using the Decision Support Acceptability Scale (DSAS). Beta-testing was conducted to assess preliminary evidence of PDA efcacy using the Decisional Confict
Scale (DCS) before and after PDA use. Readiness was evaluated using the Preparation for Decision Making Scale (PDMS).
Results The PDA included (1) a brief description of RA, (2) treatment information, and (3) a values clarifcation section. Alphatesting revealed that most patients considered that the information was presented in a good or excellent way and it could help
clarify their values and facilitate treatment decision making. Most rheumatologists agreed that the PDA was easy to understand,
to use, and allowed them to reach a shared decision. Beta-testing showed that PDA signifcantly reduced overall patients’ decisional confict [33.2 (DE: 21.4) vs 24.6 (23.5); p<0.001] and prepared the patient for decision making [PDMS: 67.5 (21.0)].
Conclusions We developed a PDA for Spanish patients with moderate-to-severe RA that reduces patients’ decisional confict
and increases their readiness for decision making. The use of this PDA in routine clinical practice may improve the quality
of the decision-making process and the quality of the choices made. [-]
Publicat a
The Patient - Patient-Centered Outcomes Research (2020) 13.Drets d'accés
info:eu-repo/semantics/openAccess
Apareix a les col.leccions
- MED_Articles [655]
Els següents fitxers sobre la llicència estan associats a aquest element:
Except where otherwise noted, this item's license is described as © The Author(s) 2019.
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License
(http://creativecommons.org/licenses/by-nc/4.0/), which permits any
noncommercial use, distribution, and reproduction in any medium,
provided you give appropriate credit to the original author(s) and the
source, provide a link to the Creative Commons license, and indicate
if changes were made.